| Document |
Document Title |
|
WO/2019/199939A1 |
In one aspect, the present disclosure provides a compound of the formula: (I) wherein the variables are as defined herein. In another aspect, the present disclosure also provides pharmaceutical compositions and methods of use of the comp...
|
|
WO/2019/194616A1 |
The present application relates to a compound of chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2019/195063A1 |
Compounds of general formula (I), and their pharmaceutically acceptable salts, wherein R1, R2, R3, R5, R6, R8, R9, A, X1, X2, and X3 are defined herein, that may be useful as inductors of type I interferon production, specifically as STI...
|
|
WO/2019/193068A1 |
The present invention relates to a process for the synthesis of a carbon labeled organic compound containing a carbon labeled carboxyl group. The present invention also concerns the use of carbon labeled organic compounds containing a ca...
|
|
WO/2019/193159A1 |
The present invention relates to bumetanide derivatives of formula (I) as well as pharmaceutical compositions comprising these compounds for use in the treatment or prevention of diseases/disorders involving Na+- K+- 2CI- - cotransporter...
|
|
WO/2019/192395A1 |
The application relates to a strongly-polarized molecule of the following general formula: wherein A denotes a group having a polarizability greater than 2 C·m2/V; R1 and R2 are respectively hydrogen, halogen, a hydroxyl group, an amino...
|
|
WO/2019/195124A1 |
Compounds of general formula (I), of general formula (II), of general formula (III), of general formula (IV), of general formula (V), of general formula (VI), and their pharmaceutically acceptable salts, wherein all variables are defined...
|
|
WO/2019/185413A1 |
The present invention relates to cyclopropyl compounds of formula I, wherein the variables have the meanings as defined in the specification, to compositions comprising them, to active compound combinations comprising them, and to their ...
|
|
WO/2019/190272A1 |
The present application relates to a novel compound and an organic light-emitting device comprising same, the novel compound according to one embodiment of the present invention being applied to an organic light-emitting device to allow ...
|
|
WO/2019/190271A1 |
The present application relates to a novel compound and an organic light-emitting device comprising same, the novel compound according to one embodiment of the present invention being applied to an organic light-emitting device to allow ...
|
|
WO/2019/190270A1 |
The present application relates to a novel compound and an organic light-emitting device comprising same, the novel compound according to one embodiment of the present invention being applied to an organic light-emitting device to allow ...
|
|
WO/2019/190230A1 |
The present specification provides a compound represented by chemical formula 1 and an organic light emitting diode comprising same.
|
|
WO/2019/180627A1 |
The present invention relates to an improved asymmetric synthesis of alpha- (diarylmethyl) alkyl amines (hereafter referred to as the compound (1)) or its pharmaceutically acceptable salt and derivatives. The process comprises an unusual...
|
|
WO/2019/177243A1 |
Disclosed are: a compound represented by chemical formula 1, an organic electronic element comprising a first electrode, a second electrode and an organic material layer between the first electrode and the second electrode; and an electr...
|
|
WO/2019/175149A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
|
WO/2019/170578A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
|
WO/2019/171278A1 |
The present invention is directed to heterocycloalkenyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the GPR120 and / or GPR40 receptors. 5 More particul...
|
|
WO/2019/173243A1 |
Disclosed herein are embodiments of polycyclic aromatic compounds and methods of making and using the same. Various different types of polycyclic ring systems are disclosed, including, but not limited to, polymeric aromatic compounds (e....
|
|
WO/2019/170572A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
|
WO/2019/169479A1 |
Compounds or pharmaceutical acceptable salts thereof of Formula (I), in which RM have the meaning described herein and pharmaceutical compositions thereof useful as antimicrobial and/or adjuvant:
|
|
WO/2019/171277A1 |
The present invention is directed to cycloalkenyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the GPR120 and / or GPR40 receptors. 5 More particularly, ...
|
|
WO/2019/166619A1 |
The present invention relates to sulfonylureas and sulfonylthioureas of formula (I) comprising a 5-membered heteroaryl ring attached to the sulfonyl group, wherein the heteroaryl ring is di-substituted at the 3- and 4- positions relative...
|
|
WO/2019/166270A1 |
The invention relates to an organic electronic device comprising at least one electron transport, electron injection or electron generation layer comprising a compound of Formula (I) wherein all positions which are not linked to a -(A)a-...
|
|
WO/2019/168378A1 |
The present specification relates to a heterocyclic compound of formula 1 and an organic light emitting device comprising same.
|
|
WO/2019/166269A1 |
The present invention relates to an organic electronic device comprising, between an anode and a cathode, at least one layer selected from an electron injection layer, an electron transport layer or an electron generation layer, the laye...
|
|
WO/2019/168140A1 |
Provided are an amide compound represented by general formula [I] or a salt thereof, an agricultural and horticultural microbicide containing the amide compound or a salt thereof as an active ingredient, and a method of using the agricul...
|
|
WO/2019/166578A1 |
The present invention relates to the field of catalytic hydrogenation and to the use of ruthenium complexes having a bidentate diphosphine ligand or two monodentate phosphine ligands, two carboxylate ligands and optionally a diamine liga...
|
|
WO/2019/159596A1 |
Provided is a method for preparing a coupled body represented by general formula (3), the coupled body being obtained by reacting a compound represented by general formula (1) and a compound represented by general formula (2) in the pres...
|
|
WO/2019/160315A1 |
The present invention relates to a heterocyclic compound of formula 1 and an organic light emitting device comprising the same.
|
|
WO/2019/157020A1 |
In one aspect, the disclosure relates to relates to substituted benzothiophene analogs which are useful as selective degraders of estrogen receptor, methods of making same, pharmaceutical compositions comprising same, and methods of trea...
|
|
WO/2019/153954A1 |
Disclosed are a multi-substituted benzene compound having biological activity, a preparation method therefor, and an application thereof. The compound of the present invention has good biological activity and the activity of inhibiting t...
|
|
WO/2019/154412A1 |
Provided are a new antimicrobial agent compound as shown in the following general formula (I), a pharmaceutically acceptable salt thereof, an ester thereof, a prodrug thereof, a solvate thereof, a deuterated compound thereof, or a stereo...
|
|
WO/2019/153373A1 |
Disclosed is a method for synthesizing a 2-benzylidene tetrahydrothiophene derivative, the method comprising the following step: reacting a (cyclopropyl ethynyl) aromatic cyclic compound as shown in formula (I) with a sulfur source under...
|
|
WO/2019/154949A1 |
The present invention relates to a new class of fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
|
|
WO/2019/154974A1 |
The present invention discloses thermally stable free thiophene croconaine dyes of formula (I), where R1-R4 are 1-20C alkyl or alkenyl groups, and their even more thermally stable complexes with anthracenyl-tetralactam macro molecules, w...
|
|
WO/2019/154950A1 |
The present invention relates to a new class of fused thiophene derivatives and their uses for treating diseases such as infection, cancer, metabolic diseases, cardiovascular diseases, iron storage disorders and inflammatory disorders.
|
|
WO/2019/147074A1 |
The present invention provides a novel heterocyclic compound and an organic light emitting device using the same.
|
|
WO/2019/143529A1 |
Engineered promiscuous biotin ligases and methods of using them in proximity labeling are described. In particular, the invention provides novel biotin ligase variants having increased promiscuous biotinylation activity capable of proxim...
|
|
WO/2019/141229A1 |
The present invention involves compounds as PPAR agonists and applications thereof. The compounds involved are novel peroxisome proliferator-activated receptor (PPAR) γ receptor agonists and can inhibit the production of mitochondrial r...
|
|
WO/2019/144132A1 |
Described herein are compounds that are estrogen receptor modulators of formula I' Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen rece...
|
|
WO/2019/143057A1 |
The present invention provides an acridine derivative represented by chemical formula (1) and an organic light-emitting diode comprising same.
|
|
WO/2019/128849A1 |
The present invention relates to an organic compound and application thereof in an organic electronic device, especially organic electroluminescent diodes. The present invention further relates to an organic electronic device comprising ...
|
|
WO/2019/131922A1 |
The present invention provides a compound that has β2-adrenergic receptor antagonist activity and carbonic anhydrase-inhibitory activity, and that exhibits excellent ocular antihypertensive activity. Specifically provided is a compound ...
|
|
WO/2019/122265A1 |
The present application relates to compounds of formula (I') or formula (I), such as formula (Ia), and their pharmaceutical compositions/preparations. This application further relates to methods of treating or preventing neurodegenerativ...
|
|
WO/2019/124537A1 |
Provided is an agricultural and horticultural fungicide manifesting a high control effect against a wide range of plant pathogens. The compound represented by formula (1): (in the formula, each symbol is as described in the specification...
|
|
WO/2019/124261A1 |
Provided is a Rotigotine-containing patch having a support layer and an adhesive layer, wherein the adhesive layer contains Rotigotine and/or a pharmaceutically acceptable salt thereof, and further contains a styrene-based thermoplastic ...
|
|
WO/2019/124538A1 |
Provided is an agricultural and horticultural fungicide exhibiting a high control effect against a wide range of plant pathogens. A compound represented by formula (1) or a salt thereof (in the formula, each symbol is as defined in the d...
|
|
WO/2019/124903A1 |
An organic light emitting device comprising a compound represented by formula 1 as a light emitting auxiliary layer material and an electronic device comprising the same are disclosed. As the compound represented by formula 1 is comprise...
|
|
WO/2019/122151A1 |
The present invention relates a compound of formula (I) in Z-isomer form (Z-(l)) or a compound of formula (I) in E-isomer form (E-(l)) wherein: R2 is a radical of formula (II) and of formula (III); X1, X2, X3, X4 and X5 are CR3 and N; Y1...
|
|
WO/2019/120099A1 |
The present invention relates to an organic mixture and the use thereof in an organic electronic device. The organic mixture comprises organic materials H1 and H2, wherein H1 is a compound as shown in the following general formula (1), a...
|
